Cytiva and LevitasBio, prominent life sciences companies, are collaborating to introduce an innovative single-cell workflow designed for genomics researchers in academia and industry. This partnership signifies a significant advancement in sample preparation techniques, expediting tasks such as tissue breakdown and purification of individual cell suspensions for single-cell analysis and other downstream applications. This development is crucial for progressing personalized medicine, offering insights into disease mechanisms, therapeutic targets, supporting oncology research, and accelerating scientific discovery.
The collaboration aims to create a streamlined, semi-automated workflow solution by leveraging the strengths of Cytiva’s VIA Extractor and LevitasBio’s LeviCell 1.0 and LeviCell EOS systems. This approach is anticipated to reduce single-cell damage or stress, enhancing overall single-cell health and ensuring the production of viable samples for subsequent genetic studies or other downstream cell-based assays.
Stephen Bell, President of Discovery & Medical at Cytiva, emphasizes the shared goal of enabling breakthrough discoveries in life sciences research. The collaboration aims to empower researchers with a more efficient and gentle approach to sample preparation. Martin Pieprzyk, CEO of LevitasBio, highlights the VIA Extractor and LeviCell platform’s ability to provide a comprehensive approach to tissue dissociation and single-cell suspension cleanup, facilitating innovative solutions in personalized medicine.
These technologies are pivotal in advancing therapeutic approaches, particularly in cancer research. The collaboration represents a significant step towards breakthroughs in research and translational applications, aligning with LevitasBio’s commitment to driving innovation in the life sciences industry. The VIA Extractor is a trademark of Global Life Sciences Solutions USA LLC, doing business as Cytiva.
Cytiva, with a global presence of nearly 15,000 associates in over 40 countries, is dedicated to advancing and accelerating therapeutic development. LevitasBio focuses on driving scientific progress and enhancing human health through cutting-edge techniques in sample preparation and cellular analysis, particularly with their exclusive label-free Levitation Technology. Both companies are committed to pushing the boundaries of scientific discovery and contributing to the betterment of human well-being.